Boston Scientific Corporation, doing business as Boston Scientific, is a manufacturer of medical devices used in interventional medical specialties, including interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiology, cardiac surgery, vascular surgery, endoscopy, oncology, urology and gynecology.
Boston Scientific is primarily known for the development of the Taxus Stent, a drug-eluting stent which is used to open clogged arteries. With the full acquisition of Cameron Health in June 2012, the company also became notable for offering a minimally invasive implantable cardioverter-defibrillator (ICD) which they call the EMBLEM Subcutaneous Implantable Defibrillator (S-ICD).
Basel Al-Qahtani, General Manager of Boston Scientific Saudi Arabia, discusses how Boston Scientific has expanded its operations to establish a fully fledged regional headquarters in the kingdom. He outlines the…
Boston Scientific’s Spain country coordinator, Carlos Sabrido, analyses the Spanish med-tech market, comments on the transformation of Boston Scientific – going from a medical devices to a health solutions company…
Tarek El Rahbani, Senior Regional Director for EMEA Growth Emerging Markets – South at Boston Scientific, highlights the transformation of the Middle East and North Africa (MENA) region’s medical technology…
Boston Scientific’s general manager for Saudi Arabia, Basel Al-Qahtani, highlights the company’s bet on the country – including the move to a direct presence and the signing of a memorandum…
Working non-stop to catch up with its footprint in other regions, Boston Scientific is investing heavily in the MENA markets. Tarek El Rahbani, managing director for the region, shares the…
Iliette Frontera, VP Operations of Boston Scientific in Puerto Rico, shares the significance of the Dorado site within the group’s global supply chain, her four priorities to ensure sustainable growth,…
Boston Scientific’s vice president and general manager Ken Spears shares his thoughts about the potential for Canada to become an early adopter of innovation and to move towards an outcome-based…
Regional leader of Boston Scientific’s Andean Region, Fernando Dussan, share his insights on why Colombia is suitable to host the core business of Boston Scientific. He speaks about the company’s…
Working to stay ahead in the highly competitive medical device field, Boston Scientific’s Philippe Hügli launched a Customer Insight Initiative in Switzerland which has served as a pilot for the…
Raffaele Stefanelli discusses the challenges of the medtech industry in Italy, the contribution of the Italian research community to Boston Scientific globally, and innovative partnership models. Could you introduce yourself…
Boston Scientific is raising the bar for medical devices and services in the field of cardiology and other pathologies, including Rhythm Management, Endoscopy, Urology Pelvic Health, and Neurostimulation. European President…
Last year, Boston Scientific took important steps to stabilise and strengthen its core businesses. Could you develop on the development trajectory of Boston Scientific in the Nordic region so far?…
Basel Al-Qahtani, General Manager of Boston Scientific Saudi Arabia, discusses how Boston Scientific has expanded its operations to establish a fully fledged regional headquarters in the kingdom. He outlines the…
A roundup of some of the biggest healthcare and pharma news from China, including the country’s struggle with a rampant COVID-19 outbreak and the external concern that surrounds it, China…
A roundup of recent pharma and healthcare news from Vietnam including Gilead’s viral hepatitis initiative, the country’s explosion of dengue fever cases and the investigation into Boston Scientific’s Vietnam operations.…
Boston Scientific’s Spain country coordinator, Carlos Sabrido, analyses the Spanish med-tech market, comments on the transformation of Boston Scientific – going from a medical devices to a health solutions company…
Tarek El Rahbani, Senior Regional Director for EMEA Growth Emerging Markets – South at Boston Scientific, highlights the transformation of the Middle East and North Africa (MENA) region’s medical technology…
The Saudi medtech market was valued at USD 2.25 billion in 2017 and is expected to reach USD 3.87 billion at a CAGR of 9.5 percent by 2023, according to…
Boston Scientific’s general manager for Saudi Arabia, Basel Al-Qahtani, highlights the company’s bet on the country – including the move to a direct presence and the signing of a memorandum…
Working non-stop to catch up with its footprint in other regions, Boston Scientific is investing heavily in the MENA markets. Tarek El Rahbani, managing director for the region, shares the…
“Medical device manufacturing has a long history on the island, starting with Baxter in the 1950s. Today, 30 world-leading medical device companies are present in Puerto Rico generating 20,000 direct…
Iliette Frontera, VP Operations of Boston Scientific in Puerto Rico, shares the significance of the Dorado site within the group’s global supply chain, her four priorities to ensure sustainable growth,…
Boston Scientific’s vice president and general manager Ken Spears shares his thoughts about the potential for Canada to become an early adopter of innovation and to move towards an outcome-based…
Regional leader of Boston Scientific’s Andean Region, Fernando Dussan, share his insights on why Colombia is suitable to host the core business of Boston Scientific. He speaks about the company’s…
See our Cookie Privacy Policy Here
